Q1 2025 Management View CEO David DeStefano highlighted Vertex's strong start to 2025, reporting $177.1 million in revenue, a ...

Vertex Pharmaceuticals' (NASDAQ: VRTX) remarkable momentum came to a screeching halt this week. The big biotech stock had ...

Vertex Pharmaceuticals hit a rough patch in Q1, reporting weaker-than-expected earnings and halting an early mRNA cystic ...

This article is the third part in a miniseries on building a project cost duration graph. The first part can be found here and the second part here. If you have already read them please ignore this ...

Listen to Story Reshma Kewalramani named in TIME magazine's 100 Most Influential People 2025 First woman to lead a major US biotech firm in 2020 Vertex got FDA approval for CRISPR-based therapy under ...

Over the past 15 years, Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products. CRISPR Therapeutics won its first regulatory ...

PR Released the Engine package with the GraphEngine node, which runs a Dynamo graph file in a separate instance of Dynamo.

odgi provides an efficient and succinct dynamic DNA sequence graph model, as well as a host of algorithms that allow the use of such graphs in bioinformatic analyses. The edges and path steps are ...